Q2 2021 Matinas BioPharma Holdings Inc Earnings Call Transcript
Welcome to the Matinas BioPharma Second Quarter 2021 Results Conference Call. (Operator Instructions)
As a reminder, this conference is being recorded.
I would now like to turn the conference over to Peter Vozzo, Investor Relations representative for Matinas BioPharma. You may begin.
Thank you, Hector. Good morning, everyone, and thank you for joining the Matinas BioPharma Second Quarter 2021 Results Conference Call. Earlier this morning, we issued a press release with our financial results along with business updates. The release is available on the Matinas BioPharma website under the Investor section. Speaking on today's call will be Jerry Jabbour, Chief Executive Officer; and Keith Kucinski, Chief Financial Officer. We also have Dr. Terry Ferguson, Chief Medical Officer; Dr. Terri Matkovits, Chief Development Officer; and Dr. Rafael Mannino, Chief Scientific Officer, who will be available to answer questions during our Q&A session.
At this time, I would like to remind our listeners
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
